: As syphilis cases rise and supply of a key treatment runs short, federal health officials are forming a task force to address the threat

Shortages of injectable penicillin made by Pfizer raise alarms as syphilis cases hit a 70-year high.

Previous post Economic Report: U.S. employment costs moderate in second quarter
Next post Realtor.com: $26.2 million will get you Vermont’s priciest home — a 345-acre compound with a golf course